Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Shares Outstanding (2021 - 2025)

Bioventus (BVS) has disclosed Shares Outstanding for 2 consecutive years, with $15.8 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Shares Outstanding fell 61.55% year-over-year to $15.8 million, compared with a TTM value of $15.8 million through Jul 2022, down 61.55%, and an annual FY2021 reading of $15.8 million, changed N/A over the prior year.
  • Shares Outstanding was $15.8 million for Q3 2022 at Bioventus, down from $61.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $61.7 million in Q3 2022 and bottomed at $15.8 million in Q2 2021.